bronchiectasis
BRONCHIECTASIS
Bronchiectasis is an irreversible pathologic dilatation or ectasia of the bronchi due to repeated airway infection and inflammation.
It enhances susceptibility to bronchial infection and increases inflammatory reaction which causes further lung damage.
Classic symptoms of of bronchiectasis are cough with chronic sputum production along with recurring infective exacerbations and hemoptysis.

Specific Therapy for Individual Causes

Hypogammaglobulinemia
  • Administer IV immunoglobulins w/ guidance & supervision from an immunologist
Primary Ciliary Dyskinesia
  • More intensive therapy based on the assumption that disease progression is more likely
  • Emphasis on physical therapy
TB, HIV, Rheumatoid Arthritis, Sarcoidosis, GERD, Chronic Rhinosinusitis
  • Treat active associated disease based on existing guidelines
  • Bronchiectasis may precede, accompany or follow the development of associated disease
Allergic Bronchopulmonary Aspergillosis (ABPA)
  • Control of asthma & prevention of damage from acute exacerbations of ABPA
  • Consider maintenance oral corticosteroids
  • Antifungal therapy (eg Itraconazole) remains 2nd-line choice, unless there is associated invasive aspergillosis
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Respirology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Roshini Claire Anthony, 19 Dec 2019

First-line treatment with the epidermal growth factor receptor tyrosine kinase inhibitor (EGFR TKI) dacomitinib demonstrated persistent survival benefit in patients with EGFR-positive advanced non-small cell lung cancer (NSCLC), according to updated results from the phase III ARCHER 1050* trial.

Pearl Toh, 03 Dec 2018
Sequential treatment with afatinib followed by osimertinib enables prolonged chemotherapy-free treatment while sustaining clinical benefit in patients with EGFR-mutation positive (EGFR+) non-small–cell lung cancer (NSCLC) who acquire T790M mutation, according to the real-world retrospective GioTag study presented at ESMO Asia 2018.